Antenatal hepatitis B
screening program effective in Italian women
(April 14, 2003 - Disease
Prevention)
Italy's antenatal hepatitis B
screening program is effective in preventing perinatal transmission of the
disease, an epidemiologic study found.
T. Stroffolini and colleagues evaluated the program's effectiveness in
preventing perinatal HBV transmission "in 11,858 pregnant women
consecutively recruited in public and private hospitals in six Italian
regions during a two month period in 2001. Of [these women], 10,881 (91.8%)
attended HBsAg antenatal screening."
The researchers reported the overall HBsAg prevalence as 1.7% (CI 95%:
1.4-1.9). By group, prevalence was 1.4% (CI 95%: 1.2-1.7) in pregnant women
born in Italy, but 5.9% (CI 95%: 4.1-8.1) in those born in Asia, Africa,
central and south America, and eastern Europe."
Statistical analysis indicated that birthplace outside of Italy, having more
than four members living in the household, and birth in a private hospital
were independent predictors of lack of adherence to HBsAg screening,
Stroffolini's group said.
"Out of the 182 newborns of HBsAg positive mothers, 172 (95.0%) were given
active plus passive immunization; this figure was 100% in newborns of
foreign mothers," the researchers reported.
"These findings evidence a good effectiveness in the prevention-of
perinatally transmitted HBV in Italy," Stroffolini and colleagues wrote,
adding, "More efforts should be addressed to improve the effectiveness of
the program among foreign pregnant women who have high rate of HBsAg and
more likely escape HBsAg screening than Italian pregnant women."
Stroffolini and coauthors published the results of their study in Vaccine
(Factors affecting the compliance of the antenatal hepatitis B screening
programme in Italy. Vaccine, 2003;21(11-12):1246-1249).
The corresponding author for this report is T. Stroffolini, Ist Super Sanita,
Epidemiology & Biostatistics Laboratory, Viale Regina Elena 299, I-00161
Rome, Italy.
The information in this article comes under the major subject areas of
Hepatitis B Virus, Infectious Disease, Obstetrics, Preventive Medicine,
Pediatrics, Public Health. This article was prepared by Hepatitis Weekly
editors from staff and other reports.
©Copyright 2003, Hepatitis
Weekly via NewsRx.com & NewsRx.net